We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
-4.64%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$11.8B
AUM Growth
+$1.34B
Cap. Flow
+$2.18B
Cap. Flow %
18.39%
Top 10 Hldgs %
3.51%
Holding
4,052
New
613
Increased
1,643
Reduced
1,246
Closed
518

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$34.6M
2
WDAY icon
Workday
WDAY
+$33.5M
3
FRC
First Republic Bank
FRC
+$31.8M
4
ZTS icon
Zoetis
ZTS
+$31.3M
5
SYF icon
Synchrony
SYF
+$31M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$35.7M
2
HON icon
Honeywell
HON
+$31.7M
3
IP icon
International Paper
IP
+$30.5M
4
ADM icon
Archer Daniels Midland
ADM
+$23.8M
5
EMR icon
Emerson Electric
EMR
+$22.5M

Sector Composition

Rank Sector Weight
1 Technology 18.12%
2 Financials 17.75%
3 Healthcare 12.17%
4 Consumer Discretionary 11.8%
5 Industrials 11.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BDTX icon
3426
Black Diamond Therapeutics
BDTX
$114M
$35K ﹤0.01%
12,560
-19,645
-61% -$71.7K
RLX icon
3427
RLX Technology
RLX
$2.44B
$35K ﹤0.01%
19,600
+3,111
+19% +$9.25K
UAVS icon
3428
AgEagle Aerial Systems
UAVS
$59.2M
$35K ﹤0.01%
+30
New +$35.4K
CCTSW
3429
DELISTED
Cactus Acquisition Corp. 1 Limited Warrant
CCTSW
$35K ﹤0.01%
+201,782
New +$84.3K
IVCBW
3430
DELISTED
Investcorp Europe Acquisition Corp I Warrant
IVCBW
$33K ﹤0.01%
+118,876
New +$35.3K
SURF
3431
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$33K ﹤0.01%
11,148
-50,333
-82% -$176K
PGRW
3432
DELISTED
Progress Acquisition Corp. Class A Common Stock
PGRW
$33K ﹤0.01%
+3,375
New +$33.1K
FRMM
3433
Forum Markets
FRMM
$83.2M
$32K ﹤0.01%
3
-5
-63% -$57.5K
IVVD icon
3434
Invivyd
IVVD
$198M
$32K ﹤0.01%
+7,100
New +$43.4K
OGI
3435
Organigram Holdings
OGI
$148M
$32K ﹤0.01%
4,825
-33,624
-87% -$207K
SNDL icon
3436
Sundial Growers
SNDL
$318M
$32K ﹤0.01%
4,610
– –
STIM icon
3437
Neuronetics
STIM
$151M
$32K ﹤0.01%
+10,443
New +$35.3K
CINC
3438
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
$32K ﹤0.01%
+1,800
New +$36.9K
OYST
3439
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$32K ﹤0.01%
2,761
– –
CNVY
3440
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
$32K ﹤0.01%
4,938
-14,215
-74% -$93.8K
ZEPP
3441
Zepp Health
ZEPP
$76.1M
$31K ﹤0.01%
2,675
-794
-23% -$12.8K
ONCR
3442
DELISTED
Oncorus, Inc.
ONCR
$31K ﹤0.01%
17,615
+2,728
+18% +$7.64K
TECX
3443
Tectonic Therapeutic
TECX
$639M
$30K ﹤0.01%
1,875
-173
-8% -$3.58K
NGD
3444
DELISTED
New Gold Inc
NGD
$29K ﹤0.01%
16,200
-354,266
-96% -$609K
TCRT icon
3445
Alaunos Therapeutics
TCRT
$4.84M
$29K ﹤0.01%
291
-733
-72% -$94.1K
VTGN icon
3446
VistaGen Therapeutics
VTGN
$11.7M
$29K ﹤0.01%
+770
New +$33.6K
LOGC
3447
DELISTED
ContextLogic
LOGC
$29K ﹤0.01%
+430
New +$30.3K
AFG icon
3448
American Financial Group
AFG
$11.9B
$28K ﹤0.01%
193
-3,466
-95% -$473K
BNGO icon
3449
Bionano Genomics
BNGO
$13.3M
$28K ﹤0.01%
18
-14
-44% -$18.9K
SYRE icon
3450
Spyre Therapeutics
SYRE
$9.29B
$28K ﹤0.01%
484
-1,754
-78% -$147K
136 137
138
139 140

Similar funds

GIM
Glenmede Investment Management Philadelphia, Pennsylvania $20.7B AUM
ECM
Eisler Capital Management London, United Kingdom $22.6B AUM 9.36% 1-Year Est. Return
JFL
Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
WIM
Waverton Investment Management London, United Kingdom $7.77B AUM 25.07% 1-Year Est. Return
AIM
AXA Investment Managers Puteaux, France $37.1B AUM
SIG
Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return

Cubist Systematic Strategies's Q1 2022 Portfolio in Review

As of Q1 2022, Cubist Systematic Strategies held 4,052 positions worth $11.8B, up 13% from $10.5B the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

Cubist Systematic Strategies deployed $2.18B of net new capital in Q1 2022, opening 613 new positions and adding to 1,643 existing holdings. Its largest new stake was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Medtronic, an estimated $35.7M trimmed.

  • Cubist Systematic Strategies's largest Q1 2022 buy was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.
  • Cubist Systematic Strategies added most to Abbott in Q1 2022, an estimated $34.6M increase.
  • Cubist Systematic Strategies's biggest Q1 2022 reduction was Medtronic, cutting an estimated $35.7M.
  • Cubist Systematic Strategies fully exited Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant in Q1 2022, selling an estimated $20.6M.
  • Cubist Systematic Strategies's ten largest holdings make up 3.5% of its $11.8B portfolio in Q1 2022.
  • Cubist Systematic Strategies opened 613 new positions and closed 518 in Q1 2022.
  • Cubist Systematic Strategies's portfolio value rose 13% quarter-over-quarter to $11.8B.

Based on Cubist Systematic Strategies's 13F filing for Q1 2022, filed 16 May 2022.